Case Report: Bullous Lung Disease Following COVID-19

Document Type

Article

Publication Title

Frontiers in medicine

Abstract

More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiological abnormalities up to 3 months after symptom onset. These radiological abnormalities are variable and most commonly include ground-glass opacities, reticulations, mosaic attenuation, parenchymal bands, interlobular septal thickening, bronchiectasis, and fibrotic-like changes. However, in this case report, we describe findings of bullous lung disease as a complication of SARS CoV-2 infection. As the pandemic continues, there is a need to understand the multiple respiratory manifestations of post-acute sequelae of COVID-19. We, therefore, present this case to add to the current body of literature describing pulmonary disease as a consequence of SARS CoV-2 infection.

First Page

770778

DOI

10.3389/fmed.2021.770778

Publication Date

1-1-2021

Identifier

34869488 (pubmed); PMC8635639 (pmc); 10.3389/fmed.2021.770778 (doi)

This document is currently not available here.

Share

COinS